Thiol reactive cyclopentenone prostaglandin, 15-deoxy-D 12,14 -prostaglandin J 2 (15d-PGJ2), induced a novel, nonapoptotic and microtubule-associated protein 1 light chain 3 (MAP1 LC3) dependent but nonautophagic form of cell death in colon, breast and prostate cancer cell lines, characterized by extensive cytoplasmic vacuolation with dilatation of endoplasmic reticulum (ER). Disruption of sulfhydryl homeostasis, which resulted in ER stress, accumulation of ubiquitinated proteins and subsequent ER dilation, contributed to peroxisome proliferatoractivated receptor g (PPARg)-independent cell death by 15d-PGJ2. Absence of intracellular organelles in these vacuoles, shown by electron microscopy and unique fragmentation of lamin B, suggested this form of cell death to be different from autophagy and apoptosis. Cell death induced by 15d-PGJ2 is prevented by cycloheximide and actinomycin D, suggesting a requirement of new protein synthesis for death with cytoplasmic vacuolation. Here, we report for the first time that upregulation and processing of autophagy marker LC3 is an important event in nonautophagic cytoplasmic vacuolation and cell death. Notably, knockdown of LC3 conferred significant protection against 15d-PGJ2-induced cytoplasmic vacuolation and cell death, suggesting a novel role of LC3 in a death process other than autophagy.
Introduction
Irradiation and chemotherapeutic drugs kill cancer cells typically through induction of apoptosis. However, most cancer cells show resistance to chemotherapy because of genetic mutations or deletions in the pro-apoptotic molecules such as Bax and/or overexpression of antiapoptotic molecules such as Bcl2 or XIAP (Reed 1999; Kaufmann and Vaux 2003; Longley and Johnston 2005) . Therefore, to achieve more efficient cancer therapeutic effects, it is important to find alternative approaches to induce nonapoptotic cell death, which has been shown to be important in physiological processes (Lockshin and Zakeri 2004) and pathological conditions (Proskuryakov et al., 2003) . Furthermore, nonapoptotic cell death has often been detected in cells that are resistant to apoptosis (Roninson et al., 2001; Naito et al., 2004) .
Several forms of nonapoptotic cell death such as autophagy, mitotic catastrophe, necrosis and paraptosis have been described (Broker et al., 2005) . Although apoptosis is characterized by cellular and nuclear fragmentation through caspase activation (Nicholson and Thornberry 1997; Porter et al., 1997) , nonapoptotic programmed cell death occurs in two major forms, namely, autophagy, involving sequestration of cytoplasm and organelles within double-membrane structures and their eventual degradation by lysosomal hydrolases (Ohsumi 2001; Huang and Klionsky 2002; Noda et al., 2002) , and paraptosis, associated with extensive cytoplasmic vacuolation, swelling of endoplasmic reticulum (ER) and mitochondria, absence of caspase activation and nuclear changes (Sperandio et al., 2000) . Though the molecular mechanisms of cell death and the basic components involved in apoptosis and autophagy are well characterized, much less is known regarding the mechanisms involved in cell death by paraptosis or cytoplasmic vacuolation.
Cyclopentenone prostaglandin derivatives that arise from free-radical-induced peroxidation of arachidonic acid have gained interest in their anti-inflammatory, antiviral and antiproliferative properties. The prostaglandin derivative 15-deoxy-D 12,14 -PGJ2 (15d-PGJ2), an endogenous ligand of peroxisome proliferator-activated receptor g (PPARg), especially has been found to have potent antiproliferative activities mediated by both PPARg-dependent and PPARg-independent mechanisms (Butler et al., 2000; Morosetti et al., 2004; Ray et al., 2006; Lin et al., 2007) . The PPARg-independent effects of 15d-PGJ2 were shown to be mediated by either reactive oxygen species (ROS) production or covalent modification of proteins by the a,b-unsaturated ketone in the cyclopentenone ring of 15d-PGJ2 (Cernuda-Morollon et al., 2001; Perez-Sala et al., 2003; Chen et al., 2002 Chen et al., , 2005 Cho et al., 2006) . Although the antiproliferative role of 15d-PGJ2 was shown to be associated with its apoptosis-inducing effects in a variety of cell lines, including pancreatic b cells, hepatic myofibroblasts, malignant B cells, breast cancer cells and glioma cells (Li et al., 2001; Morosetti et al., 2004; Chen et al., 2005; Chambers et al., 2007) , a single report suggested that 15d-PGJ2 could induce nonapoptotic, autophagic death in prostate cancer cells, which was not well characterized (Butler et al., 2000) .
Microtubule-associated protein 1 light chain 3 (MAP1 LC3) was originally identified as a protein that copurifies with large microtubule-associated proteins MAP1A and MAP1B from rat brain (Mann and Hammarback 1994) . In normal cells, LC3, a homologue of yeast APG8p, was shown to exist in two forms, LC3-I (18 kDa), a cytosolic form, and LC3-II (16 kDa), the membrane-bound shorter form derived from LC3-I by proteolysis and lipid modification (Tanida et al., 2001 (Tanida et al., , 2002 . During autophagy, LC3-I was shown to be processed into LC3-II before localizing to autophagosomal membranes, suggesting that LC3 processing is a marker of autophagy (Kabeya et al., 2000) .
Here, we report that the cyclopentenone prostaglandin 15d-PGJ2 induces death associated with vacuolation in HCT116, MDAMB231 and DU145 cancer cells derived from colon, breast and prostate, respectively. Specifically, investigation of the mechanisms by which cytoplasmic vacuolation develops suggested the dilation of ER, ER stress and the involvement of MAP1 LC3B, a protein that has been linked to autophagy. The lack of increased autophagy shown by electron microscopy and the failure of phosphoinositide 3-kinase (PI3-K) inhibitors to block either the 15d-PGJ2-mediated induction of LC3 or its proteolytic processing suggested that LC3 was involved in a nonautophagic cell death process. Interventions that blocked LC3 induction, either by gene knockdown or chemical inhibitors, dramatically reduced cytoplasmic vacuolation thus illuminating a novel role for LC3 in the ER dilation that results in death by cytoplasmic vacuolation.
Results

15d-PGJ2 induces cytoplasmic vacuolation and cell death in a variety of cancer cells
Treatment with 15d-PGJ2 induced extensive cytoplasmic vacuolation in apoptosis-resistant HCT116 colon cancer cells, MDAMB231 breast cancer cells and prostate cancer cell line DU145 within 9 h ( Figure 1a ) with no obvious nuclear changes (Figures 1a and 3a) . The death-inducing effects of 15d-PGJ2 on cancer cells were determined by both clonogenic survival assay and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The number of surviving colonies decreased after 15d-PGJ2 treatment in a dose-dependent manner in all three cell lines (Figure 1b ), suggesting cytotoxic effects of 15d-PGJ2 on cancer cells. Cells that were incubated with 15d-PGJ2 for 9 h exhibited cytoplasmic vacuolation and died afterward even if 15d-PGJ2 was absent or continually present (Figure 1c ), suggesting vacuolation results in irreversible cell injury to cancer cells. Cytoplasmic vacuolation and cell death induced by 15d-PGJ2 were not blocked by PPARg antagonists GW9662 and T0070907 ( Supplementary  Figure 1 ), suggesting involvement of PPARg-independent pathways. Inclusion of z-VAD or q-VD, broadspectrum inhibitors of caspases, prevented neither cytoplasmic vacuolation (Figure 2a ) nor cell death ( Figure 2b ) in HCT116 cells. Moreover, screening for active caspase-3 in 15d-PGJ2 cells by western blotting or immunofluorescence gave no signal (data not shown), suggesting that caspases and caspase activation are not involved in 15d-PGJ2-induced vacuolation cell death. Similar results were also seen in MDAMB231 and DU145 (data not shown). In addition, 15d-PGJ2-treated HCT116 colon cancer cells showed random DNA fragmentation that appears as a smear during agarose gel electrophoresis (Figure 2c , lanes 6 and 7). In contrast, 15d-PGJ2-treated, nontransformed but immortalized, rat kidney proximal tubule cells (RPTC) underwent apoptotic cell death and their DNA gave a characteristic ladder-like pattern on agarose gels ( Figure 2c , lane 2). To further distinguish vacuolation death from apoptosis, we have compared proteolytic degradation of nuclear lamin B in HCT116 cells undergoing vacuolation death, in the presence or absence of caspase inhibitor z-VAD, with HeLa cells undergoing apoptotic cell death induced by actinomycin D (act D). Lamin B showed a distinct cleavage pattern in cells dying by vacuolation ( Figure 2d , lanes 2 and 3) compared to cells dying by apoptosis ( Figure 2d , lane 5). These results clearly suggested that cytoplasmic vacuolation results in a distinct but novel form of nonapoptotic cell death.
Cytoplasmic vacuoles induced by 15d-PGJ2 are the dilated cisternae of ER By electron microscopy, 15d-PGJ2-induced vacuoles appeared clear and lacked any visible cytoplasmic material thus ruling out autophagy as the mode of cell death ( Figure 3a ). Furthermore, they appeared to have been derived from fused and swollen ER cisternae that had pushed the cytoplasm and other organelles closer to the nucleus (Figure 3a ). To confirm that 15d-PGJ2induced vacuoles were derived from ER cisternae, we obtained electron micrographs at a higher resolution and analysed them for rough endoplasmic reticulum (RER). As shown in Figure 3b , ribosomes were aligned with RER membrane in normal cells. In 15d-PGJ2treated cells, swollen RER that were shedding ribosomes could be identified (see arrows in Figure 3b ). To further confirm that 15d-PGJ2-induced vacuoles were derived from ER cisternae, we immunostained cells with ERspecific markers Calnexin or Calreticulin, which showed a reticular pattern characteristic of ER in normal cells. Following treatment with 15d-PGJ2, antibodies to ER markers stained numerous cytoplasmic vacuoles (Figure 3c and Supplementary Figure 7 ).
Upregulation of ER stress proteins and ubiquitination by 15d-PGJ2
Marked dilation of ER cisternae by 15d-PGJ2 ( Figure 3 ) suggested that swelling of the ER compartment might Figure 2 ); in addition there is an increase in ubiquitinated proteins (Figures 4a and b ), reflecting the activation of the unfolded protein response (UPR) pathway. Because Bip/GRP78, an ER luminal HSP70 homologue, is often associated with misfolded protein aggregates in the ER (Hurtley et al., 1989) , we analysed its distribution in Triton-soluble and Triton-insoluble fractions upon 15d-PGJ2 treatment. In control cells, Bip was detected mostly in the Triton-soluble fraction (S); however, 15d-PGJ2 treatment resulted in the migration of Bip to Triton insoluble low-speed and high-speed pellet fractions (P1 and P2, Figure 4c ). Similarly, CHOP was detected predominantly in the Triton-soluble fraction in control cells, whereas 15d-PGJ2 treatment resulted in CHOP translocation to Triton-insoluble lowspeed pellet fraction (P1), which is consistent with the fact that ER stress causes nuclear translocation of CHOP (Ghribi et al., 2001) . In contrast, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a cytosolic protein was present mostly in Triton-soluble fraction (S) both in untreated and treated cells. Because valosincontaining protein (VCP) is involved in expelling misfolded proteins from the ER to degrade them in the cytoplasm by the ubiquitin-proteasome system, we compared the relative distribution of VCP in normal and 15d-PGJ2-treated cells. Although VCP was predominantly associated with Triton-soluble fraction in normal cells (S), 15d-PGJ2 treatment resulted in its migration to Triton-insoluble pellet fractions (P1 and P2; Figure 4c ). Similar redistribution of VCP was also reported under velcade-induced cytoplasmic vacuolation (Mimnaugh et al., 2006) .
15d-PGJ2-induced cytoplasmic vacuolation requires new protein synthesis. Cytoplasmic vacuolation induced by 15d-PGJ2 was completely blocked by the inhibitors of transcription and translation, act D and cycloheximide (CHX), respectively (Figure 4d ), suggesting its similarity with paraptosis described by Sperandio et al. (2000) Figure 1 15-Deoxy-D 12,14 -prostaglandin J 2 (15d-PGJ2) induces cytoplasmic vacuolation and cell death in cancer cells: HCT116 colon cancer cells, MDAMB231 breast cancer cells and DU145 prostate cancer cells were treated with 20 mM of 15d-PGJ2 for 9 h. (a) Phasecontrast images showing cytoplasmic vacuolation in 15d-PGJ2-treated cells (right panels). Untreated cells were shown in the left panels. (b) Death-inducing effects of 15d-PGJ2 on HCT116, MDAMB231 and DU145 cancer cells was determined by clonogenic survival after 9 h treatment as described in Results section. Data represent average of three independent experiments with standard error. (c) Decreased cell viability of HCT116 cells as assessed by MTT assay with either continuous presence of drug for 24, 48 and 72 h or treated with drug for 9 h and shifted to normal medium for remaining periods ( þ 9 h/À15 h, þ 9 h/À39 h, þ 9 h/À63 h). Effect of autophagy inhibitor wortmannin (WM) or apoptosis inhibitor (q-VD) on cell viability was also tested. Data represent average of three independent experiments ± s.d. both in terms of vacuolation and its prevention by act D and CHX. Inclusion of act D or CHX dramatically reduced ER stress, as shown by the lack of upregulation of ER stress markers Bip and CHOP (Supplementary Figure 4) , and preserved the viability of 15d-PGJ2 treated cancer cells as shown by complete restoration of their ability to form colonies in a clonogenic assay ( Figure 4e ). Increased ubiquitination and aggregation of proteins into Triton-insoluble fraction, by 15d-PGJ2, was also prevented by CHX and act D (Figure 4f ).
Taken together, it appears that 15d-PGJ2 induces extensive misfolding of newly synthesized proteins forming insoluble aggregates resulting in ER swelling, and that this process depends on transcription and translation of new protein.
Autophagy-independent expression and processing of LC3 induced by 15d-PGJ2. Surprisingly, 15d-PGJ2 induced B10-fold increase in LC3-I, the cytosolic form of MAP1 LC3, and B15to 20-fold increase in its processed Figure 3 ). Because LC3 was shown to be involved in the formation of vacuoles during autophagy, we checked for similarities between autophagy-and 15d-PGJ2-induced cytoplasmic vacuolation in terms of LC3 processing. PI3-K inhibitors are known to block the autophagymediated processing of LC3. Therefore, we tested the sensitivity of cytoplasmic vacuolation-mediated LC3 processing to these inhibitors, and compared the LC3 processing that occurs during serum starvation induced autophagy in HeLa cells (Kabeya et al., 2000) and 15d-PGJ2-induced cytoplasmic vacuolation in HCT116 cells. Starvation in HeLa cells did not increase the expression of LC3 but only increased processing of LC3-I to LC3-II (Figure 5c, compare lanes 1 and 2) , which was prevented by all three inhibitors of PI3-K, wortmannin (WM), LY294002 (LY) and 3-methyladenine (3-MA; Figure 5c ). In contrast, increased expression and processing of LC3 in vacuolated HCT116 cells was not blocked by PI3-K inhibitors WM, LY and 3-MA ( Figure 5e ). Analysis of cytoplasm and membrane fractions of autophagic HeLa cells and vacuolated HCT116 cells clearly indicated that in both LC3-I was localized to the cytoplasm, whereas the processed LC3-II was recruited to the membrane-bound fraction (Figures 5d and f) . Thus, our results suggested that the mechanisms involved in the induction and processing of LC3 during cytoplasmic vacuolation are distinct from the mechanisms involved in autophagy-induced LC3 processing. Because we do not yet have suitable antibodies for LC3 immunofluorescence, we generated HCT116 cells that constitutively expressed GFP-LC3. Though we observed increased granulation of GFP-LC3 during starvation-induced autophagy, 15d-PGJ2-induced cytoplasmic vacuolation resulted in perivacuolar distribution of GFP-LC3 ( Figure 5g ). Because three isoforms of MAP1 LC3 exist in human cells, we asked the question which isoforms are being induced during cytoplasmic vacuolation. Interestingly, only MAP1 LC3B but not MAP1 LC3A or MAP1 LC3C was dramatically induced during 15d-PGJ2-mediated cytoplasmic vacuolation (Figure 5h ).
Thiol antioxidants but not other ROS scavengers block 15d-PGJ2-induced cytoplasmic vacuolation. The antineoplastic effects of 15d-PGJ2 were earlier shown to be exerted through ROS production (Chen et al., 2002) . Therefore, we tested the effect of several antioxidants on 15d-PGJ2-induced vacuolation and cell death in HCT116 cells. To our surprise, ROS scavengers TEMPOL, a superoxide dismutase mimetic, and Trolox, a vitamin E analog, failed to block 15d-PGJ2-induced cytoplasmic vacuolation and cell death in HCT116 colon cancer cells (Figures 6a and b) . In sharp contrast, the thiol antioxidants N-a-acetyl-L-cysteine (NAC) and N-mercaptopropionylglycine (NMPG) prevented 15d-PGJ2-induced cytoplasmic vacuolation in HCT116 cells ( Figure 6a ) and restored their ability to survive and form clones in a clonogenic assay (Figure 6b ). Moreover, these thiol antioxidants, but not TEMPOL and Trolox, also significantly prevented 15d-PGJ2-induced expression of ER stress markers Bip and CHOP (Figure 6c) , and reduced the accumulation of ubiquitinated proteins (Figure 6d ). Furthermore, both NAC and NMPG, but not TEMPOL and Trolox, blocked 15d-PGJ2-induced expression and processing of LC3 (Figure 6c ). These results indicate that the effects of 15d-PGJ2 are probably mediated through its ability to covalently modify free sulfhydryl groups on proteins and not through ROS production.
Role of MAP kinases in 15d-PGJ2-induced cytoplasmic vacuolation. To elucidate the signaling mechanisms that are involved in regulating 15d-PGJ2-induced cytoplasmic vacuolation, we monitored the activation of MAP kinases by immunoblotting with phosphospecific antibodies. Treatment with 15d-PGJ2 resulted in the pre-dominant activation of MAP kinase, ERK (extracellular signal-regulated kinase) and marginal activation of two other MAP kinases, SAPK/JNK and p38 (Figure 7a ). However, only inhibitors of ERK pathway, U0126 and MEK inhibitor I but not the inactive analog U0124, showed significant reduction in the number of vacuolated cells (Figure 7c ), whereas inhibitors of p38 (SB203580) and SAPK (SP600125) had no effect (Figure 7c ). Interestingly, ERK inhibitors also decreased 15d-PGJ2induced expression and processing of LC3 (Figure 7b,  lanes 4 and 8) , whereas p38 and SAPK inhibitors had no effect (Figure 7b, lanes 12, 14 and 16 ).
Loss of lysosomal protease activity is not responsible for LC3 induction. To find out whether expression of LC3 is related to decreased lysosomal function by 15d-PGJ2, we analysed the effect of 15d-PGJ2, leupeptin, q-VD on Cathepsin B and L, lysosomal endopeptidases. Leupep- tin completely blocked lysosomal cathepsin activity when it was added to either cell extracts (Figure 8a ) or intact cells (Figure 8b) , but caused only a slight increase in LC3 protein levels in the intact cells (Figure 8c, lane  4) . In contrast, 15d-PGJ2 did not affect cathepsin activity when it was added directly to cell extracts (Figure 8a ), caused only a B50% decrease of cathepsin activity when it was added to intact cells (Figure 8b ), but caused large increases of LC3 protein in the intact cells (Figure 8c, lane 2) , suggesting that lysosomal inhibition did not affect LC3 induction. In fact, blockage of 15d- Figure 4) and MAPK inhibitors suggests alternative novel mechanisms to be responsible for LC3 upregulation.
PGJ2-induced LC3 expression by transcription and translational inhibitors (Supplementary
MAP1 LC3B knockdown conferred protection against 15d-PGJ2-induced cytoplasmic vacuolation and cell death. A dose-and time-dependent increase in the expression and processing of LC3 by 15d-PGJ2, and prevention of LC3 induction and processing by reagents that blocked cytoplasmic vacuolation suggested that (g) HCT116 cells that are constitutively expressing GFP-LC3 were exposed to starvation or 15d-PGJ2 and were analysed by confocal microscopy. The bar in these diagrams indicates 10 mm length. (h) Quantitative real-time PCR to analyse the expression of three isoforms of MAP1 LC3 using primers described in the Materials and methods section. Inset shows relative expression of LC3 isoforms analysed by agarose gel electrophoresis after 17 cycles of RT-PCR.
LC3 may have an important function in cytoplasmic vacuolation death. To test the function LC3 has in cytoplasmic vacuolation, we blocked LC3 expression by gene knockdown techniques using shRNA. Initially, three different shRNA sequences were screened to knockdown LC3 expression by transient transfection and one sequence was found to be more effective than others in reducing LC3 expression and cytoplasmic vacuolation (not shown). We used this construct for stably expressing MAP1 LC3B-shRNA in HCT116 cells. A GFP-shRNA construct was used as a control. Knockdown of LC3 (Figure 9a ) conferred significant protection against 15d-PGJ2-induced cytoplasmic vacuolation as revealed by phase-contrast microscopy (Figures 9b and c) . Although 15d-PGJ2-treated LC3 knockdown cells showed only moderate decreases of Bip expression and ubiquitinated protein accumulation, CHOP induction was significantly blocked (Figure 9a ). Furthermore, cell viability assays revealed that knockdown of LC3 significantly protected HCT116 cells from 15d-PGJ2-induced cell death (Figure 9d ). Decreased expression of LC3 also resulted in slower growth rate of HCT116 cells, which was consistent with increased expression of p21, p27 and p53 proteins (Figure 9e ).
Discussion
This study sheds light on the mechanism of death by cytoplasmic vacuolation induced by 15d-PGJ2 in the cancer cell lines HCT116, DU145 and MDAMB231. The results clearly demonstrated that 15d-PGJ2 induces caspase-independent cell death characterized by extensive cytoplasmic vacuolation in apoptosis-resistant cancer cell lines. This form of death was associated with ER stress and required new protein synthesis (Figure 4 ). 15d-PGJ2 resulted in massive increases of ubiquitinated proteins and their aggregation as evidenced by their detection in the Triton-insoluble fractions (Figure 4) . On the basis of our results, it appears that disruption of sulfhydryl homeostasis might be the critical factor in this form of cell death as only thiol antioxidants, NAC and NMPG, but not other ROS scavengers TEMPOL and Trolox, prevented the accumulation of ubiquitinated proteins, induction of ER stress markers and cytoplasmic vacuolation ( Figure 6) .
The present study also shows for the first time that 15d-PGJ2-induced nonautophagic cell death was associated with induction and processing of the autophagy marker MAP1 LC3B ( Figure 5 ). Unlike autophagy, where all three isoforms of LC3 seem to mark the autophagic vacuoles (He et al., 2003) , cytoplasmic vacuolation likely requires only LC3B isoform (Figure 5h ). However, the LC3 processing that occurred during cytoplasmic vacuolation was shown to be quite distinct from autophagy-mediated processing of LC3. Both class I and class III PI3-K inhibitors, which blocked autophagic processing of LC3, failed to prevent 15d-PGJ2-mediated induction and conversion of LC3 ( Figure 5) . The exact function of LC3 in 15d-PGJ2- induced ER membrane fusion and formation of cytoplasmic vacuoles still remains to be determined. Notably, all agents that blocked cytoplasmic vacuolation-NAC, NMPG, act D, CHX, U0126 and MEK inhibitor I-inhibited both the induction and processing of LC3 ( Figures 6 and 7 and Supplementary Figure 4 ). In addition, the protection offered by LC3 knockdown clearly points to its critical function in cytoplasmic vacuolation death induced by 15d-PGJ2 (Figure 9 ). Activation of MAPK signaling by 15d-PGJ2 has been reported in various cell types Kimura et al., 2008) . In the present study, activation of subfamilies MAPK was noted (Figure 7) . Specific inhibitors of ERK significantly prevented 15d-PGJ2-induced cytoplasmic vacuolation as well as LC3 induction and processing, indicating the involvement of MAPK pathways.
Accumulation of misfolded proteins invariably results in the activation of several intracellular signaling pathways that include the UPR and ER-associated degradation (ERAD) to protect cells from proteotoxicity. Therefore, enhanced rates of accumulation of misfolded proteins increase the dependency of cells on optimal proteasomal function. However, failure of the proteasomal machinery would lead to further accumulation of misfolded proteins in the ER and cytoplasm making them toxic to the cells. In this regard, proteasome inhibitors appear to be attractive anti-neoplastic therapeutic drugs. Overwhelming of cells by misfolded proteins often results in the failure of UPR and ERAD, the ER quality control machineries, to remove these unwanted toxic proteins and thus may lead to cell death. Indeed, cancer cells are much more sensitive to the death effects of proteasome inhibition than normal cells (Nawrocki et al., 2005) .
Because 15d-PGJ2-induced cytoplasmic vacuolation was indeed due to ER dysfunction, this form of cell death warrants further attention in the treatment of cancer. In this regard, drugs that simulate the actions of 15d-PGJ2 may be more suitable as anti-neoplastic agent as they could have the potential to covalently modify sulfhydryl groups causing protein misfolding as well as inhibit the proteasomal degradation machinery (Ishii et al., 2005; Wang et al., 2006) . Newly synthesized proteins with exposed sulfhydryls are likely to be more sensitive than mature proteins for covalent modification by 15d-PGJ2 analogs. Because of their absolute requirement for new protein synthesis, rapidly growing cancer cells would be more susceptible than quiescent normal cells to 15d-PGJ2-induced cell death. It is noteworthy that CHX and act D, drugs that block new protein synthesis, protected cancer cells from 15d-PGJ2-induced cytoplasmic vacuolation death by reducing the overall load of misfolded proteins on the ER. It is interesting to note that the slower growth rate of LC3 knockdown cells may also contribute to a decreased rate of misfolded protein formation, thus reducing the subsequent load on ER. Interestingly, other cyclopentenone prostaglandins such as PGA1 and PGA2 were less potent than 15d-PGJ2 in inducing cytoplasmic vacuolation, ER stress or LC3 expression (Supplementary , an inactive analog of U0126, SB203580 (SB203) at 10 mM and 20 mM (2 Â ), inhibitor of P38 MAP kinase and SP600125 (20 mM), JNK pathway inhibitor on 15d-PGJ2-induced expression and processing of LC3. After 1 h of preincubation with the above inhibitors, cells were treated with 15d-PGJ2 for 9 h and then were probed for LC3 by western blotting of total cell lysates. (c) Effect of MAP kinase inhibitors on 15d-PGJ2-induced cytoplasmic vacuolation. Cells were treated as described above, phase-contrast images were obtained from different fields and number of vacuolated cells was counted in at least 100 cells for each condition and data represent an average of three independent experiments. Figure 5) , thus suggesting uniqueness of 15d-PGJ2 in mediating nonautophagic and nonapoptotic cell death. Recently, it was found that autophagy accelerates the degradation of p62 protein, also called sequestosome 1, which is known to associate with ubiquitinated proteins (Bjorkoy et al., 2005; Pursiheimo et al., 2009) . It has been reported that there is a good correlation between inhibition of autophagy and increased levels of p62 (Bjorkoy et al., 2005; Pankiv et al., 2007) . Interestingly, our results show that 15d-PGJ2 treatment causes increased levels of p62, suggesting that autophagy may be inhibited in vacuolated cells (Supplementary Figure  6) , which is further supported by the inhibition of lysosomal cathepsin activity by 15d-PGJ2 (Figure 8) .
Overall, the above studies highlight the importance of drug-induced cytoplasmic vacuolation as an alternative form of programmed cell death, which can be further exploited to treat apoptosis-resistant tumors.
Materials and methods
Materials HCT116 cells (a kind gift from Dr Bert Vogelstein) were grown in Mc COY's 5A supplemented with fetal bovine serum and Penicillin-Streptomycin. HeLa, DU145 and MDAMB231 cells were from ATCC (Manassas, VA, USA) and were grown according to recommendations from ATCC. The compounds SB203580, SP600125, MEK inhibitor I, U0126, U0124, NAC, TEMPOL and Trolox were purchased from Calbiochem (San Diego, CA, USA). 15d-PGJ2, prostaglandins A1, A2 and D2, GW9662 and T0070907 were from Cayman Chemicals (Ann Arbor, MI, USA). Actinomycin D, CHX, NMPG, LY, WM and 3-MA were obtained from Sigma (St Louis, MO, USA), zVAD and qVD from MP Biomedicals (Aurora, OH, USA). Bip rat monoclonal and CHOP and lamin B rabbit polyclonals, p53 mouse monoclonal antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The p21 mouse monoclonal antibody was from Upstate Biotechnology (Lake Placid, NY, USA). P27 antibody was from Lab Vision (Fremont, CA, USA). Ubiquitin antibody was from Biomol (Plymouth Meeting, PA, USA) and VCP antibody was from Affinity BioReagents (Golden, CO, USA). Antibodies to phospho-p38, phospho-SAPK, phospho-ERK were from Cell Signaling Technology (Danvers, MA, USA). Calreticulin rabbit polyclonal was a kind gift from Dr Robert A Clark, UTHSCSA. LC3 antibody and GFP-LC3 constructs were kind gifts from Dr Tamotsu Yoshimori, Osaka University (Japan). MAP1 LC3B antibody was also obtained from Cell Signaling Technology. Horseradish peroxidase-conjugated and preadsorbed secondary antibodies to mouse and rabbit were obtained from Jackson Immunoresearch Laboratories (West Grove, PA, USA). All other reagents were of the highest grade available.
15d-PGJ2 treatment and cell viability
Cells were plated at B0.11 Â 10 6 cells per cm 2 with suitable growth medium in 35 mm dishes or multiwell plates. After overnight growth, cells were incubated with indicated concentrations of 15d-PGJ2 in fresh complete growth medium Figure 8 Increase of light chain 3 (LC3) protein levels by 15-deoxy-D 12,14 -prostaglandin J 2 (15d-PGJ2) is not through inhibition of lysosomal protease activity. (a) Cathepsin L activity in untreated HCT116 cell extracts was measured through hydrolysis of Z-Phe-Arg-AMC as described in Materials and methods section. Extracts were preincubated with either 15d-PGJ2 or leupeptin before measuring the activity. (b) Cells were treated with either leupeptin, or 15d-PGJ2 or 15d-PGJ2 with wortmannin (WM), an autophagy inhibitor or 15d-PGJ2 with caspase inhibitor q-VD for 9 h. Membrane-bound fractions were collected and assayed for Cathepsin L activity. (c) LC3 expression in HCT116 cells treated for 9 h with either cathepsin inhibitor, leupeptin or 15d-PGJ2 or caspase inhibitor; qVD was analysed by immunoblotting. for indicated times. Control and experimental cells after 9 h of treatment with 15d-PGJ2 at concentrations indicated as well as in combination with different inhibitors, were either trypsinized for Clonogenic survival assay, a method of choice to determine cell reproductive death after treatment with cytotoxic agents. Cell viability was also determined by MTT assay (Mosmann 1983) after 9 h or 24, 48 and 72 h incubation of cells with 15d-PGJ2. For each data point, triplicate cultures were prepared and data represent average of at least three independent experiments.
Autophagy
To induce autophagy, we starved HeLa or HCT116 cells in Hanks' balanced salt solution for 1 h at 37 1C with or without the inhibitors of autophagy, WM (0.1, 0.5 and 1 mM), LY (50 and 100 mM) and 3-MA (10 mM), after which cells were lysed in 2 Â Laemmli buffer and were subjected to immunoanalysis using anti-LC3 antibody.
Cathepsin assay
Cytosolic fraction and membrane fraction that contain organelle-bound proteins including lysosomal enzymes were prepared as described before (Saikumar et al., 1998) . To measure Cathepsin B and L activity, we added 25 mg of membrane lysates to reaction mixtures containing 50 mM peptide substrate (z-Phe-Arg-AMC), 100 mM HEPES, 10% sucrose, 0.1% CHAPS, 1 mM EDTA and 10 mM DTT (pH 7.4) in a total volume of 200 ml and incubated at 37 1C for 1 h. Production of 7-amino-4-methylcoumarin (AMC) was monitored in a SpectroFluor plate reader (Tecan US Inc., Research Triangle Park, NC, USA) using excitation wavelength 360 nm and emission wavelength 460 nm.
DNA laddering
DNA fragmentation was analysed as described previously (Saikumar et al., 1998) . Control and experimental cells were lysed in hypotonic buffer (10 mM Tris, 2 mM EDTA, pH 7.4) containing 0.5% Triton X-100. The resultant supernatant was treated with proteinase K and RNase A, extracted with phenol:chloroform and ethanol precipitated. DNA precipitates were dissolved in 10 mM Tris, 1 mM EDTA at pH 8.0 and analysed by 1.5% agarose gel electrophoresis.
Electron microscopy
Control and experimental cells in a 35 mm dish were fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer and were then incubated with osmium tetroxide (OsO 4 ) at 4 1C for 1 h. The cells were then incubated overnight in 1% uranyl acetate at 4 1C after which they were further processed at the Electron Microscopy Core Facility in the Department of Pathology, UTHSCSA.
Immunocytochemistry
Control and 15d-PGJ2-treated experimental cells were fixed with 4% paraformaldehyde in phosphate-buffered saline and then were exposed to primary antibody, anti-calnexin or anti calreticulin followed by CY3-conjugated anti-rabbit or antimouse secondary antibodies. Coverslips were mounted with prolonged antifade mounting media (Invitrogen, Carlsbad, CA, USA) with or without DAPI and cells were visualized in Olympus FV-500 laser scanning confocal fluorescent microscope.
Subcellular fractionation
Cytosolic and membrane fractions were prepared as described before (Saikumar et al., 1998) . To obtain detergent soluble and insoluble fractions, we lysed control and experimental cells in dishes with the lysis buffer containing 1% Triton X-100 in isotonic buffer A containing protease inhibitors, scraped, collected into centrifuge tubes and incubated over ice for 30 min. The lysates were centrifuged for 20 min at 1500 g in 4 1C to obtain pellet P1 and the resulting supernatant was further centrifuged at 100 000 g for 1 h to obtain pellet P2 and supernatant S. The pellets P1 and P2 were dissolved in 2 Â Laemmli buffer.
Immunoanalysis
All proteins from different cell lysates were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) in XCell II mini cell on 10% or 4-12% (gradient) NuPAGE gels (Invitrogen) with MOPS or MES running buffer, then were electroblotted onto PVDF membranes (0.2 mm) using manufacturer's directions. Western blotting using appropriate primary antibodies and peroxidase-conjugated suitable secondary antibodies was performed on the above membranes. Chemiluminescent substrates from Pierce (Rockford, IL, USA) were used to detect antigen-antibody complexes on the PVDF membrane. Densitometry was performed on immunoblots using Alpha Imager apparatus (Alpha Innotech, San Leandro, CA, USA) equipped with AlphaView software.
Quantitative real-time-PCR for LC3 expression
To identify which of MAP1 LC3 isoforms are upregulated by 15d-PGJ2 treatment, we used quantitative real-time PCR (q-PCR). Total RNA from HCT116 cells treated with 15d-PGJ2 for 0, 2, 6 or 9 h was isolated using RNAeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Total RNA (1 mg) was reverse transcribed in 50 ml at 48 1C for 2 h using High Capacity cDNA Archive Kit from Applied Biosystems (Foster City, CA, USA). Amplification of cDNA was carried out using the following primers and SYBR green PCR master mix in an Applied Biosystems 7500 Real-Time PCR System. The primers used for amplification are: MAP1 LC3A forward primer (CGTCCTGGACAAGAC-CAAGT) and reverse primer (CTCGTCTTTCTCCTGCT CGT); MAP1 LC3B forward primer (AGCAGCATCCAAC CAAAATC) and reverse primer (CTGTGTCCGTTCACCA ACAG); MAP1 LC3C forward primer (CGGAAGCCTTT-TACTTGCTG) and reverse primer (GTCTGTCCTCA AGGCTGCTC). The threshold cycle (C t ) values, as defined by the default setting, were measured by an ABI Prism 7500 Sequence Detection System. 18srRNA was used as an internal control. Triplicate samples were measured and averaged.
LC3 knockdown
To stably knockdown endogenous LC3 expression by RNAi, we cloned the short-hairpin RNA expression cassettes generated by annealing 64-nucleotide sequences containing the 19-nucleotide sequence from the target transcripts into pSUPER vector driven by the human H1 promoter. The 19nucleotide sequence was designed from the following region of human LC3B (bases 418-436). Vector containing short-hairpin sequence for GFP was used as a control. All constructs were verified by DNA sequencing.
